tiprankstipranks
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
US Market

Ocular Therapeutix (OCUL) Income Statement

Compare
1,417 Followers

Ocular Therapeutix Income Statement

Last quarter (Q4 2024), Ocular Therapeutix's total revenue was $17.08M, an increase of 15.40% from the same quarter last year. In Q4, Ocular Therapeutix's net income was $-48.39M. See Ocular Therapeutix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 63.72M$ 58.44M$ 51.49M$ 43.52M$ 17.40M
Gross Profit
$ 58.10M$ 53.16M$ 46.95M$ 39.12M$ 15.32M
Operating Expenses
$ 229.88M$ 135.54M$ 125.61M$ 117.15M$ 78.17M
Depreciation and Amortization
$ 3.79M$ 2.98M$ 2.11M$ 2.42M$ 2.77M
EBITDA
$ -176.14M$ -66.42M$ -61.91M$ -75.62M$ -146.09M
Operating Income
$ -171.78M$ -82.38M$ -78.65M$ -78.04M$ -62.85M
Other Income/Expenses
$ -21.73M$ 1.65M$ 7.62M$ 71.48M$ -92.79M
Pretax Income
$ -193.51M$ -80.74M$ -71.04M$ -6.55M$ -155.64M
Net Income
$ -193.51M$ -80.74M$ -63.42M$ -10.80M$ -159.63M
Per Share Metrics
Basic EPS
$ -1.22$ -1.09$ -0.83$ -0.14$ -2.63
Diluted EPS
$ -1.22$ -1.02$ -0.83$ -0.13$ -2.63
Weighted Average Shares Outstanding
158.27M 79.83M 76.88M 76.39M 60.75M
Weighted Average Shares Outstanding (Diluted)
158.27M 85.60M 76.88M 82.16M 60.75M
Currency in USD

Ocular Therapeutix Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis